NanoViricides Inc
NanoViricides Inc (NNVC) Implied Volatility Current
NNVC implied volatility is 484%. IV Rank is 71%, placing current premiums in the top of their 52-week range.
Read more
Tracking NNVC implied volatility helps you identify when options premiums on NanoViricides Inc are historically cheap or expensive, and where the best trades are hiding. NanoViricides Inc implied volatility reflects the market's expectation of future price movement: when NNVC IV rises, option premiums increase, creating opportunities for sellers, and when it drops, buyers can find cheaper contracts. Use our scanner to monitor NanoViricides Inc's implied volatility current levels in real time and filter for high-probability trades.
Implied volatility is derived from option prices using models like Black-Scholes and represents the annualized expected move of an underlying stock. For NNVC, tracking metrics like NNVC IV rank helps traders understand whether current implied volatility is historically high or low. IV rank compares today's reading against the past year's range — a high rank on NNVC signals rich premiums and potential mean-reversion, while a low rank may favor long options strategies.
NanoViricides, Inc., a nano-biopharmaceutical research and development company, discovers, develops, and commercializes drugs for the treatment of viral infections. The company develops Human Coronavirus Program for COVID-19 seasonal coronavirus affliction; HerpeCide Dermal Topical and Eye Drops for the treatment of shingles, PHN, chickenpox, herpes, recurrent herpes labialis, genital herpes, and ocular herpes keratitis; and HerpeCide IntraOcular Injection for viral acute retinal necrosis The company also develops FluCide Broad-Spectrum Anti-Influenza nanoviricide, which is injectable for hospitalized patients and oral for outpatients; Nanoviricide eye drops for viral diseases of the external eye; DengueCide for treatment of various types of Dengue viruses; and HIVCide, an escape-resistant anti-HIV nanoviricide.
In addition, it develops other nanoviricides drug projects for treatment of different viruses and indications; and HerpeCide program expansion drug projects for different herpes viruses for different indications. NanoViricides, Inc. was founded in 2005 and is based in Shelton, Connecticut.
Premium sellers, directional traders, and spread builders all need the same starting point: a clear read on where NNVC implied volatility sits today versus where it has been. Our scanner ranks NanoViricides Inc implied volatility against its historical range, surfaces extremes in NNVC IV rank, and pairs every reading with the trades that exploit it. Stop guessing whether NanoViricides Inc IV is rich or cheap — measure it, then act on it.
Implied Volatility
IV is slightly elevated - premiums are richer, leaning toward sellers.
As of September 18, 2026
Trade options with IV on your side
Track NNVC IV rank across every expiration, spot where volatility is elevated, and identify high-probability setups before the window closes.
Start your 14-day free trial→